Skip to content

In the BioHarmony Drug Report Database


Sogroya (somapacitan) is a small molecule pharmaceutical. Somapacitan was first approved as Sogroya on 2021-03-31. It has been approved in Europe to treat growth.
Trade Name Sogroya
Common Name Somapacitan
Indication growth
Drug Class Growth hormone derivatives
Get full access now